Mirrabooka Investments (ASX: MIR) Share Price and News

Mr Walls is currently the Chief Executive Officer of Objective Corporation Limited, a position he has held since founding the business in 1987. He has experience as a CEO and a Director. He also brings experience in the IT industry.

Dr Fairley has more than 30 years of operational experience in the pharmaceutical and biotechnology industries working in senior management roles with companies including CSL and Faulding (now Pfizer) and has most recently joined the board of Calvary Healthcare, which operates hospitals and aged care facilities. Dr Fairley is also a Director of the Baker Heart and Diabetes Institute and a member of the Victorian Trade and Investment Advisory Board and acted as an adviser to the Carnegie Innovation Fund for more than 10 years. Dr Fairley is a past Director of Starpharma and the Melbourne Business School and past member of the Australian Federal Government's Commonwealth Science Council, Pharmaceutical Industry Working Group. She has also participated in a number of federal and state government Ministerial advisory councils in pharmaceuticals, economic development and innovation. She is Member of the Investment Committee.

Mr Richards has over 25 years' experience in the investment banking industry, with 19 years at JBWere and Goldman Sachs JBWere, where he was an equity partner for 17 years, working primarily in equity capital markets. He is Chairman of the Investment Committee. `

Mr Dwyer is a Director of the Dwyer Foundation, Scanlon Capital Pty Ltd, Willed Technologies Pty Ltd, Willed Pty Ltd and Eldin Risk Partners Limited and Chairman of Credit Clear Limited and Envest Group Pty Ltd. Mr Dwyer held a senior executive position with OAMPS Insurance Brokers Limited and was previously Regional Underwriter with CGU. Mr Dwyer is an investor in insurance distribution businesses, which includes insurance broking, authorised representatives, franchisees, underwriting agencies, online insurance platforms, claims management, Lloyd's broking and reinsurance broking.

Mr Freeman was a Partner with Goldman Sachs JBWere, where he spent 12 years advising the investment companies on their investment and dealing activities. He has a knowledge and experience of investment markets and the Company's approaches, policies and processes. He is also Managing Director of Australian Foundation Investment Company Limited, Djerriwarrh Investments Limited and AMCIL Limited. He is Member of the Investment Committee.

Ms Kimmitt's executive career has included a range of senior roles with the Victorian Gambling and Casino Control Commission, MinterEllison, Ernst & Young and the International Accounting Standards Board (IASB). She joined the IASB at its inception in 2001 and is one of the founding developers of International Financial Reporting Standards (IFRS). She is a Non-Executive Director of Trawalla Group. Ms Kimmett was appointed in 2020 to Monash University's Industry Council of Advisors. She was formerly a Non Executive Director and Chair of the Finance, Audit and Risk Committee of the Melbourne Business School since 2010, and a member of the Business Council of Australia's Economic Policy and Competitiveness Committee between 2018 and 2021. She is member of the Investment Committee.

-

-

-

-

-